complete drugs study

Upload: peace-andong-perocho

Post on 04-Jun-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/13/2019 Complete Drugs Study

    1/13

    Drug Study

  • 8/13/2019 Complete Drugs Study

    2/13

    DRUG INDICATION MECHANISM OF ACTION SIDE EFFECT NURSING INTERVENTION

    Brand Name:

    Medrol

    Generic Name:

    methylprednisolone

    Classification:

    Glucocorticoid

    Dosage:

    16 mg/tab; 1tab

    Route:

    PO

    Frequency:

    BID; p.c. (post cebum)/ aft

    er meals

    Suppression of

    inflammatory and allergic

    disorders

    As a glucocorticoid, it

    has marked

    antiinflamatory action

    due to its ability to

    inhibit prostaglandin

    synthesis. As an

    immunosuppressant, it

    inhibits phagocytosis and

    migration of

    macrophages and

    leukocytes to the site of

    inflammation as well as

    stabilizes lysosomes to

    prevent release of

    enzymes and reverses

    increased capillary

    permeability.

    GI upset

    Headache

    DizzinessInsomnia

    Weight gain

    1. Assess patients condition

    before therapy and regularly

    thereafter to monitor drug

    effectiveness.

    2. Periodically monitor adrenal

    function for suppression of

    hypothalamic-pituitary-

    adrenal axis.

    3. Monitor patients weight

    (report weekly gain >5lbs),

    blood pressure, potassium,

    blood glucose, urine glucose

    and plasma cortisol levels.

    4. Monitor vital signs regularly.

    Assess for edema,

    hypertension and other

    cardiac symptoms and report

    chest pain. Also monitor

    input-output ratio.

    5. Carefully assess for infection

    because drug can mask

    infection symptom even afterwithdrawal of medications:

    increased temperature and

    WBC.

    6. Assess mental status note for

    aggression and

    behavioural/mood changes.

    7. Give medicine with food or

    milk to decrease GI

    symptoms.

    CONTRAINDICATION ADVERSE REACTION

    Systemic fungal

    infections

    Septic shock

    Hypersensitivity

    Administration of

    live/ live attenuated

    vaccine

    Tuberculous or

    syphilitic processesin the area to be

    treated

    Viral diseases (e.g.

    varicella, herpes

    zoster)

    Euphoria

    Pseudomotor

    cerebri

    Heart failure

    Pancreatitis

    Carbohydrate

    intolerance

    Hypokalemia Hyperglycemia

    Hirsutism

    Skin eruptions

  • 8/13/2019 Complete Drugs Study

    3/13

    DRUG INDICATION MECHANISM OF

    ACTION

    SIDE EFFECT NURSING INTERVENTION

    Brand Name:

    Tergecef

    Generic Name:

    cefixime

    Classification:

    Cephalosporin,

    third generation

    Dosage:

    200mg/cap; 1 cap

    Route:

    PO

    Frequency:

    BID

    Secondary infections

    of chronic respiratory

    tract diseases

    Inhibits bacterila cell

    wall synthesis,

    rendering cell wall

    osmotically unstable,

    leading to cell death.

    Nausea and vomiting

    Abdominal pain

    Dyspepsia

    Flatulence

    1. Assess patients previous

    sensitivity reaction to

    penicillin or other

    cephalosporins. Cross-

    sensitivity between

    penicillins and

    cephalosporins is common.

    2. Obtain Culture and

    Sensitivity before beginning

    drug therapy to identify if

    correct treatment has been

    initiated.

    3. Assess renal function beforeand during therapy: urine

    output, BUN and creatinine.

    Monitor for nephrotoxicity.

    4. Teach patient to take

    medication as directed;

    complete entire

    prescription. May cause GI

    upset; report persistent

    adverse effects esp.

    Diarrhea.

    5. May alter results of urine

    glucose and ketone testing.

    CONTRAINDICATION ADVERSE REACTIONHypersensitivity

    History of shock due

    to any ingredient of

    this product.

    Shock

    Granulocytopenia

    Acute renal failure

    Interstitial pneumonia

    Lyells syndrome

    Diarrhea

  • 8/13/2019 Complete Drugs Study

    4/13

    DRUG INDICATION MECHANISM OF ACTION SIDE EFFECT NURSING INTERVENTION

    Brand Name:

    Dilatam

    Generic Name:

    diltazem

    Classification:

    Calcium channel blocker

    Dosage:

    30mg/tab; tab

    Route:

    PO

    Frequency:

    TID

    Treatment of angina

    pectoris caused coronary

    artery spasm.

    Inhibits calcium ion influx

    across cell membrane

    during cardiac

    depolarization, produces

    relaxation of coronary

    vascular smooth muscle,

    dilates coronary arteries,

    slows SA/AV node

    conduction times, dilates

    peripheral arteries.

    Edema

    Dizziness

    Headache

    Infection

    Rhinitis

    Dyspnea

    1. Instruct patient to limit

    caffeine consumption.

    2. Caution patient to change

    positions slowly to

    minimize orthostatic

    hypotension.

    3. Caution patient to wear

    protective clothing and

    use sunscreen to prevent

    photosensitivity reactions

    4. Inform patient to take

    extended-release capsules

    on an empty stomach at

    same time each day. Donot open, chew, or crush;

    swallow whole.

    5. Teach patient that drug

    does not cure high Bp or

    angina just controls it so

    continue taking as

    prescribed even when BP

    is not elevated or angina

    symptoms are not

    present.

    6. Teach patient to continue

    diet (low fat/ low Na),

    regular exercise, and

    decreased caffeine; stop

    tobacco and alcohol.

    Reduce fluid and salt

    intake to control swelling.

    CONTRAINDICATION ADVERSE REACTION

    Patients with the sick sinussyndrome, pre-existing

    second- or third-

    degreeatrioventricular

    block, or marked

    bradycardia.

    HypotensionBradycardia

    Atrioventricular block

    Asystole

    Sinus arrest

  • 8/13/2019 Complete Drugs Study

    5/13

    DRUG INDICATION MECHANISM OF ACTION SIDE EFFECT NURSING INTERVENTION

    Brand Name:

    Tazocin

    Generic Name:

    piperacillin/tazobactam

    Classification:

    Antibiotic, penicillin

    Dosage:

    4.5gm

    Route:IV

    Frequency:

    q8

    Community-acquired

    pneumonia of moderate

    severity caused by

    piperacillin resistant, beta-lactamase-producing strains

    of haemophilus influenzae.

    A combination of

    piperacillin sodiumand

    tazobactam sodium, a beta-

    lactamase inhibitor.Tazobactam inhibits beta-

    lactamases, thus ensuring

    activity of piperacillin

    against beta-lactamase-

    producing microorganisms.

    Thus, tazobactam broadens

    the antibiotic spectrum of

    piperacillin to those

    bacteria normally resistant

    to it.

    Diarrhea

    Constipation

    Dyspepsia

    HeadacheAbdominal pain

    1. Note reasons for therapy,

    type, location,

    characteristics of signs and

    symptoms.

    2. List any sensitivity to

    penicillins, cephalosporins,

    beta-lactamase inhibitors,

    or other allergens.

    3. List drugs prescribed to

    ensure none interact

    unfavourably.

    4. Monitor C&S, urinalysis,

    hematologic, coagulation

    profile, electrolytes, renal

    and liver function test.

    Reduce dosage with renal

    impairment.

    CONTRAINDICATION ADVERSE REACTION

    Hypersensitivity to

    penicillins, cephalosporins,

    or beta-lactamase

    inhibitors.

    Agitation

    Anxiety

    Pruritus

    Thrombocytopenia

    Edema

    Moniliasis

    Hemolytic anemia

  • 8/13/2019 Complete Drugs Study

    6/13

    DRUG INDICATION MECHANISM OF ACTION SIDE EFFECT NURSING INTERVENTION

    Brand Name:

    Fluimucil

    Generic Name:

    acetylcysteine

    Classification:

    Mucolytic

    Dosage:

    600mg/tab;

    1tab on 75ml water

    Route:

    PO

    Frequency:

    OD

    Treatment of respiratory

    affections characterized by

    thick and viscous hyper

    secretions: acute and

    chronic bronchitis and its

    exacerbation.

    Decreases viscosity of

    respiratory tract secretions

    and promote their removal

    by breaking disulfide

    bonds.

    Bronchial/tracheal

    irritation

    Rash

    Stomatitis

    Nausea & Vomiting

    1. Asses patients

    history of underlying

    condition, cough:

    type, frequency,

    character

    2. Assess patients

    respiration and

    pulmonary

    secretions, exercise

    caution on patients

    with respiratory

    insufficiency and

    history ofbronchospasm.

    3. Instruct patient to

    follow directions

    exactly. Explain

    importance of using

    drug as directed.

    4. Tell patient to avoid

    hazardous activitiesuntil patients is

    stabilized on this

    medication, avoid

    alcohol and other

    CNS depressants,

    these will enhance

    sedating properties

    of this drugs.

    CONTRAINDICATION ADVERSE REACTION

    Hypersensitivity

    Phenylketonuria

    (contains aspartame)

    Generalized urticaria

    accompanied by mildfever

    Hypotension

    Wheezing

    Dyspnea

  • 8/13/2019 Complete Drugs Study

    7/13

    DRUG INDICATION MECHANISM OF ACTION SIDE EFFECT NURSING INTERVENTION

    Brand Name:

    Losec

    Generic Name:

    omeprazole

    Classification:

    Proton pump inhibitor

    Dosage:

    40mg/tab; 1tab

    Route:

    PO

    Frequency:

    OD

    Short term treatment of

    gastroesophageal reflux

    disease (GERD)

    Suppresses gastric

    secretion by inhibiting

    hydrogen/potassiumATPase enzyme system in

    the gastric parietal cell:

    characterized as a gastric

    acid pump inhibitor, since

    it blocks the final step of

    acid.

    Headache

    Abdominal pain

    DairrheaURTI

    Dizziness

    Rash

    1. List reason for therapy,

    triggers, frequency,

    characteristics of signs

    and symptoms.2. Record abdominal

    assessments,

    radiologic/endoscopic

    findings, and H. Pylori

    results.

    3. Monitor urinalysis, CBC,

    and liver function test;

    adjust dosage withhepatic dysfunction.

    4. Take capsule at least 1 hr

    before eating and swallow

    whole; do not open,

    chew, or crush. Antacids

    can be administered with

    omeprazole.

    5. Teach patient to report

    any changes in urinary

    elimination, pain,

    discomfort or persistent

    diarrhea.

    6. Avoid alcohol and OTC

    agents as well as foods

    known to cause GI

    upset/irritation.

    CONTRAINDICATION ADVERSE REACTION

    Hypersensitivity

    Combination therapy

    with clarythromycin

    should not be used in

    patients with hepayic

    impairment.

    Pancreatitis

    Liver necrosis

    Hepatic failure

    Toxic epidermal

    necrolysis

    Agranulocytosis

  • 8/13/2019 Complete Drugs Study

    8/13

    DRUG INDICATION MECHANISM OF ACTION SIDE EFFECT NURSING INTERVENTION

    Brand Name:

    Micardis

    Generic Name:telmisartan

    Classification:

    Antihypertensive,

    angiotensin II receptor

    blocker

    Dosage:

    40/12.5 mg/tab; 1 tab

    Route:

    PO

    Frequency:

    OD

    For hypertension The angiotensin II receptor

    antagonists competitively

    block the angiotensin AT1

    recepor located in vascularsmooth muscles and the

    adrenal glands, thus

    blocking the vasoconstrictor

    and aldosterone-secreting

    effects of angiotensin II.

    Thus, BP is reduced.

    Diarrhea

    Pain

    Sinusitis

    MyalgiaAbdominal pain

    Cough

    Flu-like symptoms

    1. May be taken with or

    without food.

    2. Teach patient to

    store drug from 15-30

    degrees Celsius. Donot remove tablet

    from blisters until just

    before use.

    3. Take as directed at

    the same time daily

    with or without food.

    4. Teach patient to use

    drug with caution,

    may experience

    dizziness related to

    low BP. Change

    positions slowly.

    5. Teach patient to have

    regular exercise, low-

    salt diet, and lifestyle

    changes (e.g., no

    smoking, low alcohol,

    low-fat diet, low

    stress, adequate rest)

    contribute to

    enhanced Bp control.

    Monitor BP regularly.

    CONTRAINDICATION ADVERSE REACTION

    Use with caution in

    impaired hepatic function

    or in biliary obstructive

    disorders.

    Anaphylaxis

    Angioedema

    Cardiac arrest

    Hepatic necrosis

  • 8/13/2019 Complete Drugs Study

    9/13

    DRUG INDICATION MECHANISM OF ACTION SIDE EFFECT NURSING INTERVENTION

    Brand Name:

    Solu-cortef

    Generic Name:

    hydrocortisone

    Classification:

    Glucocorticoid

    Dosage:

    100 mg

    Route:

    IV

    Frequency:

    Q 8

    Respiratory disease Glucocorticoid with anti

    inflammatory effect

    because of its ability to

    inhibit prostaglandin

    synthesis, inhibit migration

    of macrophages, leucocytes

    and fibroblasts at sites of

    inflammation, phagocytosis

    and lysosomal enzyme

    release. It also cause the

    reversal of increased

    capillary permeability.

    Flushing

    Sweating

    Headache

    Nausea

    Diarrhea

    1. Assess patients

    condition before

    starting therapy and

    reassess regularly.

    2. Monitor patients

    weight, blood

    pressure, glucose and

    electrolyte levels.

    3. Monitor weight,

    input-output ratio,

    urine output and

    increasing edema

    (daily). Report

    hypertension, edema,

    cardiac symptoms or

    weekly weight gain of

    >5lbs.

    4. Assess carefully for

    signs of infection

    especially fever and

    WBC count (even

    after withdrawal ofmedication) because

    the drug masks

    infection symptoms.

    5. Caution patient on

    use of OTC products

    that contain

    salicylates and

    alcohol.

    CONTRAINDICATION ADVERSE REACTION

    Nonasthmatic bronchial

    disease

    Administration of live virus

    vaccines in patients

    receiving

    immunosuppressive

    corticoid doses

    Acute glomerulonephritis

    Thrombophlibitis

    Circulatory collapse

    Pancreatitis

    Thrombocytopenia

    Hemorrhage

    Fractures

  • 8/13/2019 Complete Drugs Study

    10/13

    DRUG INDICATION MECHANISM OF ACTION SIDE EFFECT NURSING INTERVENTION

    Brand Name:

    Lasix

    Generic Name:

    furosemide

    Classification:

    Diuretic, loop

    Dosage:

    40 mg

    Route:

    IV

    Frequency:

    For acute pulmonary edema

    Inhibits the reabsorption of

    sodium and chloride in the

    proximal and distal tubules

    as well as the ascending

    loop of Henle; this results in

    the excretion of sodium,

    chloride, and, to a lasser

    degree, potassium and

    carbonate ions. Diuretic

    action is independent of

    changes in clients acid-

    base balance.

    Jaundice

    Tinnitus

    Hypotension

    Pancreatitis

    Abdominal pain

    Electrolyte depletion

    1. Should be given in the

    morning on an empty

    stomach to enhance

    absorption and avoid

    interruption of sleep

    from frequent

    urination.

    2. Drug may cause BP

    drop. Change position

    slowly. Avoid alcohol

    and do not exercise

    heavily in hot

    weather.

    3. Use sunscreens and

    protective clothing

    when sun expose to

    minimize the effects

    of drug induced

    photosensitivity.

    4. Record Bp and

    weights; report any

    gains of >2 lb per dayor >5 lb per week.

    5. Supplement diet with

    vegetables and fruits

    that are high in

    potassium (bananas,

    oranges) if oral

    supplements are not

    prescribed.

    CONTRAINDICATION ADVERSE REACTION

    Never use with ethacrynic

    acid.

    Anuria

    Hypersensitivity to drug

    Severe renal disease

    associated with azotemia

    and oliguria

    Hepatic coma associated

    with electrolyte depletion.

    Agranulocytosis

    Aplastic anemia

    Thrombophlebitis

    Cardiac arrest

  • 8/13/2019 Complete Drugs Study

    11/13

    DRUG INDICATION MECHANISM OF ACTION SIDE EFFECT NURSING INTERVENTION

    Brand Name:

    Lanoxin

    Generic Name:

    digoxin

    Classification:

    Cardiac glycoside

    Dosage:

    0.25/tab; 1tab

    Route:

    PO

    Frequency:

    OD

    Congestive heart failure,

    including that due to

    venous congestion,

    edema, dyspnea,

    orthopnea, and cardiacarrhythmia.

    Inhibits sodium-potassium

    activated adenosine

    triphosphatase, thereby

    allowing influx of calcium

    into the intrecellular space(cytoplasm), more

    available calcium

    promotes increased force

    by myocardial contraction

    (positive inotropic effect)

    resulting to increased

    cardiac output. It also acts

    on the CNS to enhancevagal tone, causing the

    decrease of conduction

    speed between the SA and

    AV nodes. This vagal

    stimulation decreases the

    cardiac rate (negative

    chronotropic effect) to

    prevent arrhythmia.

    Tachycardia

    Headache

    Dizziness

    Anorexia

    Blurred or yellow

    vision

    1. Obtain patients history of underlying

    condition before therapy.

    2. Assess and document apical pulse( rate,

    rhythm, character) for 1 full minute

    before giving drug. If pulse

  • 8/13/2019 Complete Drugs Study

    12/13

    DRUG INDICATION MECHANISM OF ACTION SIDE EFFECT NURSING INTERVENTION

    Brand Name:

    Zykast

    Generic Name:

    Montelukast

    sodium +

    levotirizine

    dihydrochloride

    Classification:

    Repiratory/ Astham

    & COPD Drugs/

    Leukotriene

    Antagonists,

    Allergy/

    Antihistamines, 3rd

    generation

    Dosage:

    10mg/5mg/tab;

    1tab

    Route:

    PO

    Frequency:

    ODHS

    Relief of symptoms

    associated with seasonal

    and perennial allergic

    rhinitis

    Montelukast inhibits

    bronchoconstriction due to

    antigen challenge. Montelukast

    is a selective leukotriene

    receptor antagonist of the

    cysteinyl leukotriene Cys

    LT1receptor. The cysteinyl

    leukotrienes (LTC4, LTD4,LTE4)

    are products of arachidonic acid

    metabolism that are released

    from various cells, including

    mast cells andeosinophils. They

    bind to cysteinyl leukotriene

    receptors(CysLT) found in the

    human airway.

    Fever

    Abdominal pains

    Fatigue

    Headache

    Cough

    1. Teach patient to take this drug

    regularly as prescribed; do not

    stop taking this drug during

    symptom-free periods; do not

    stop taking this drug without

    consulting your health careprovider. Continue taking any

    other antiasthma drugs that

    have been prescribed for you.

    Notify your health care provider

    if your asthma becomes worse.2. Do not take this drug for an

    acute asthma attack or

    acute bronchospasm; this drug

    is not a bronchodilator, and

    routine emergency proceduresshould be followed during acute

    attacks.3. Avoid the use of aspirin

    or NSAIDs if you have a known

    sensitivity to these

    drugs. Montelukast will not

    prevent reactions.4. You may experience these side

    effects: Dizziness (use cautionwhen driving or performing

    activities that require

    alertness); nausea, vomiting

    (eat frequent small meals, take

    drug with food); headache

    (analgesics may be

    available). Report fever, acute

    asthma

    attacks, flulike symptoms,

    lethargy.

    CONTRAINDICATION ADVERSE REACTION

    Hypersensitivity to

    one of its component.

    Severe renal or

    hepatic impairment.

    Hepatitis

    Myalgia

    Urticaria

    Convulsion

    Angioneurotic edema

    Influenza

  • 8/13/2019 Complete Drugs Study

    13/13

    DRUG INDICATION MECHANISM OF ACTION SIDE EFFECT NURSING INTERVENTION

    Brand Name:

    Maxivent

    Generic Name:

    doxofylline

    Classification:

    Antiasthmatic

    Dosage:

    400mg/tab; tab

    Route:

    PO

    Frequency:

    BID

    Bronchial asthma

    & pulmonary

    disease w/ spasticbronchial

    component.

    Adrenergic bronchodilators

    and phosphodiesterase

    inhibitors bothworkby increasing intracellular level

    of cyclic-3,5- adenosine

    monophosphate(cAMP);

    adrenergics by increasing

    production

    and phosphodiesterase

    inhibitors by decreasing

    breakdown. Increased levels of

    cAMP produce

    bronchodilation.Corticosteroi

    ds act by decreasing airwa

    y inflammation. Antichol in

    erg ics (ipratropium) produce

    brondhodilation by decreasin

    g intracellular levels of cyclic

    guanosine monophosphate

    (cGMP). Leukotrienereceptor antagonists andmast

    cell stabilizers decrease the

    release of substances that

    can contribute to bronchospasm

    Nausea

    vomiting

    epigastric pain

    1. Assess lung so unds,

    pulse and blood pressure

    before administration

    and during peak of

    medication. Not amount,

    color, and character of

    sputum produced.

    2. Monitor pulmonary

    function tests before

    initiating therapy and

    periodically during therapy to

    determine effectiveness of

    medication.

    3 . O bs er ve for par adox ical

    bronchospasm (wheezing

    ). If co nditions occur,with

    hold medication and notify

    physician of other health

    care professional

    immediately

    CONTRAINDICAT

    ION

    ADVERSE REACTION

    Acute MI

    hypotension

    cephalalgia

    irritability

    insomnia

    tachycardia

    extrasystole

    tachypnea

    hyperglycemia

    albuminuria